Effectiveness and safety of secukinumab in ankylosing spondylitis: real-life data from Midlands Ankylosing Spondylitis Collaboration (MASC)
Rheumatol Adv Pract
.
2023 Mar 8;7(1):rkad029.
doi: 10.1093/rap/rkad029.
eCollection 2023.
Authors
Adeola Ajibade
1
,
Haridha Pandian
1
,
Nibha Jain
2
,
Latika Gupta
1
3
,
Ramasharan Laxminarayan
4
,
Arumugam Moorthy
3
,
Roshan Amarasena
5
,
Natasha Cox
6
,
Hem Sapkota
1
,
Girish Kakade
1
,
Srinivasa Elamanchi
3
,
Athiveeraramapandian Prabu
3
,
Elaf Al-Samaraaie
3
,
Nick Barkham
1
Affiliations
1
Rheumatology Department, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK.
2
Rheumatology Department, University Hospitals of Leicester NHS Trust, Leicester, UK.
3
Rheumatology Department, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.
4
Rheumatology Department, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.
5
Rheumatology Department, The Robert Jones & Agnes Hunt Orthopaedic Hospital NHS Foundation Trust, Oswestry, UK.
6
Primary Health Care Sciences, Keele University, Newcastle-under-Lyme, UK.
PMID:
36938322
PMCID:
PMC10023240
DOI:
10.1093/rap/rkad029
No abstract available